Lemaitre Vascular (LMAT) Depreciation & Amortization (CF) (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $2.6 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) rose 2.78% year-over-year to $2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.5 million (up 7.27% YoY) and the FY2025 annual result came in at $10.4 million, up 8.43% from the prior year.
• Depreciation & Amortization (CF) grew to $2.6 million in Q1 2026 per LMAT's latest filing, from $2.6 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $2.6 million in Q2 2025 and bottomed at $2.3 million in Q4 2022.
• The 5-year median for Depreciation & Amortization (CF) is $2.4 million (2024), against an average of $2.4 million.
• The widest annual swing landed in 2022, when Depreciation & Amortization (CF) dropped 20.67%; it then increased 11.07% in 2025.
• Tracing LMAT's Depreciation & Amortization (CF) over 5 years: stood at $2.3 million in 2022, then gained by 6.77% to $2.4 million in 2023, then decreased by 1.11% to $2.4 million in 2024, then advanced by 7.82% to $2.6 million in 2025, then gained by 0.69% to $2.6 million in 2026.
• Per Business Quant, the three latest LMAT Depreciation & Amortization (CF) figures stand at $2.6 million (Q1 2026), $2.6 million (Q4 2025), and $2.6 million (Q3 2025).

Peer Comparison